News Sentiment

STIM sentiment intelligence

Neuronetics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 70 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 1.76 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 59

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+24.8% over one week, +32.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM)

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 24.8% Price confirming higher
Trend fit Trend inactive 32.3% over four weeks
Fair value -24.8% Below fair value
Market Dynamics buy signal Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 54
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 59
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 12
TradingKey 7
TradingView 5
The Manila Times 2
Quiver Quantitative 2
GlobeNewswire 2
Kavout | AI 1

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 26
Balance sheet 2
Analyst action 2
Deals and strategy 1
Regulatory and legal 1
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 70
GuruFocus Direct company coverage

Insider Buying: Jorey Chernett Acquires 35,000 Shares of Neuronetics Inc (STIM)

Jorey Chernett, a 10% owner of Neuronetics Inc (STIM), purchased 35,000 shares on July 14, 2026, increasing his total holdings to 10,588,988 shares. This acquisition is part of a trend where Chernett has bought over 3.6 million shares in the past year with no sales. Neuronetics I

Tone
Positive 70/100
Event
Deals and strategy
Published
15 Jul 2026 16:19
Source
GuruFocus
Investing.com Canada Direct company coverage

Form 4 Neuronetics Inc For: 15 July By Investing.com

This article from Investing.com announces the filing of Form 4 for Neuronetics Inc. on July 15. The brief piece includes the stock symbol STIM and notes a 3.95% increase for the company. It serves as a concise update on a regulatory filing for Neuronetics.

Tone
Neutral 50/100
Event
Regulatory and legal
Published
15 Jul 2026 13:19
Source
Investing.com Canada
Investing.com Direct company coverage

Neuronetics: Jorey Chernett acquires $62,300 common stock

Jorey Chernett, a 10% owner of Neuronetics, Inc. (NASDAQ:STIM), acquired 35,000 shares of common stock for $62,300 on July 14, 2026. This transaction increased his direct holdings to 10,588,988 shares. Despite a recent 15% stock return, InvestingPro analysis indicates the shares

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 13:19
Source
Investing.com
Stock Titan Direct company coverage

Neuronetics (STIM) EVP Cory Anderson reports PRSU awards tied to cash metrics

Neuronetics' EVP & Gen. Manager, Greenbrook, Cory Anderson, filed an initial statement of beneficial ownership, revealing holdings of common stock and performance restricted stock units (PRSUs). These PRSUs, totaling up to 15,000 and 18,335 shares, vest between December 2026 and

Tone
Neutral 50/100
Event
Balance sheet
Published
13 Jul 2026 20:41
Source
Stock Titan
The Manila Times Direct company coverage

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

Neuronetics, Inc. announced its management will participate in a panel discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The panel, titled "Commercializing the Next Wave of Novel Neuropsychiatric Drugs," will include Compass Pathways. Ne

Tone
Positive 64/100
Event
Market update
Published
06 Jul 2026 12:41
Source
The Manila Times
Quiver Quantitative Direct company coverage

Neuronetics to Participate at B. Riley Securities’ Mind, Muscle & Vision Summit

Neuronetics, Inc. will participate in the B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The company will be part of a panel discussion focused on "Commercializing the Next Wave of Novel Neuropsychiatric Drugs" and will also hold one-on-one meeting

Tone
Positive 63/100
Event
Market update
Published
06 Jul 2026 12:41
Source
Quiver Quantitative
Ad-hoc-news.de Direct company coverage

Neuronetics stock leans on its core therapy platform.

Neuronetics (NASDAQ:STIM) stock continues to focus on its medical-device business, with investors looking at the company's NeuroStar therapy platform and its commercial rollout. The company's core product, NeuroStar Advanced Therapy, is a noninvasive treatment system for depressi

Tone
Positive 67/100
Event
Market update
Published
03 Jul 2026 17:39
Source
Ad-hoc-news.de
marketscreener.com Direct company coverage

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Growth Benchmark

Neuronetics, Inc. (NasdaqGM: STIM) has been removed from the Russell 2000 Growth Benchmark and several other Russell indices, including the Russell 2000, Russell 2500, Russell 3000, and Russell 3000E indices and their growth benchmarks. This change follows a series of recent lead

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 11:12
Source
marketscreener.com
TradingView Direct company coverage

Price to sales forward of Neuronetics, Inc. – NASDAQ:STIM

This page provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically focusing on its forward price-to-sales ratio. It appears to be a financial data page from TradingView, offering an overview of the company's financials for investors and analysts. Despite

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 20:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Neuronetics, Inc. – NASDAQ:STIM

This article provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically its enterprise value to EBITDA forward. It indicates data is sourced from ICE Data Services, FactSet, American Bankers Association, and Quartr for SEC filings.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 18:39
Source
TradingView
TradingKey Direct company coverage

Neuronetics Inc (STIM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Neuronetics Inc (STIM) currently has a price momentum score of 6.93, ranking 131st in its industry, with its stock trading between resistance at $1.66 and support at $1.09, suggesting suitability for range-bound swing trading. Technical indicators show a mixed signal with 2 buy,

Tone
Positive 58/100
Event
Market update
Published
26 Jun 2026 17:10
Source
TradingKey
TradingView Direct company coverage

Neuronetics, Inc. Actuals & Estimates (NASDAQ:STIM)

This article provides an overview of Neuronetics, Inc. (NASDAQ: STIM) stock, including its current price, market capitalization, volatility, and analyst forecasts. It also details financial data such as past earnings, revenue, net income, and upcoming earnings report dates. The c

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 16:39
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Neuronetics, Inc. – NASDAQ:STIM

This article provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication and no trades were recorded. The content is presented within the context of Tradi

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 03:10
Source
TradingView
TradingView Direct company coverage

STIM Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Neuronetics, Inc. (STIM) stock, based on analysis from three different analysts. It includes current stock performance metrics, historical price data, financial statements, and an earnings report schedule. The article also pro

Tone
Positive 60/100
Event
Earnings
Published
26 Jun 2026 00:08
Source
TradingView
Investing.com Nigeria Direct company coverage

Form 8K Neuronetics Inc For: 23 June By Investing.com

This article announces that Neuronetics Inc. filed a Form 8K on June 23. The Form 8K is a crucial SEC filing that companies use to announce unscheduled material events or corporate changes that are important to shareholders and the SEC. Further details about the content of the fi

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 15:40
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Cory Anderson named EVP, GM of Greenbrook at Neuronetics (NASDAQ: STIM)

Neuronetics, Inc. has promoted Cory Anderson to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026. Anderson, who previously served as Senior Vice President, Chief Technology Officer, will receive an annual base salary of $425,000 and a target discret

Tone
Neutral 50/100
Event
Analyst action
Published
23 Jun 2026 20:10
Source
Stock Titan
TradingKey Direct company coverage

Neuronetics Inc (STIM) Institutional Confidence

The article reports on Neuronetics Inc's (STIM) institutional confidence score, which is currently 5.00, placing it 109th out of 203 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has increased by 11.24% quarter-over-quarter, reaching 6

Tone
Positive 60/100
Event
Market update
Published
19 Jun 2026 01:40
Source
TradingKey
TradingKey Direct company coverage

Neuronetics Inc (STIM) Earnings Forecast: Future EPS & Revenue Growth Estimates

Neuronetics Inc (STIM) currently holds an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $7.00, with a consensus "Buy" rating based on 3 analysts. The company's expected revenue for th

Tone
Positive 76/100
Event
Earnings
Published
18 Jun 2026 14:09
Source
TradingKey
TradingKey Direct company coverage

Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Neuronetics Inc (STIM) by business segments and regional contributions. The data, updated on April 6th, shows that Clinic revenue and Treatment sessions are the largest business segments, while the United States accounts for the vast

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 05:40
Source
TradingKey
TradingKey Direct company coverage

Neuronetics Inc (STIM) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Neuronetics Inc (STIM), indicating its current valuation score is 8.49, ranking it 94 out of 204 in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -2.24, noting its position relative to recent

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:09
Source
TradingKey
TradingKey Direct company coverage

Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Neuronetics Inc (STIM), outlining its major shareholders and institutional holdings as of recent reporting periods. It identifies top shareholders such as Madryn Asset Management, LP, Chernett (Jorey), and Parian Ultreia LP, and c

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 00:40
Source
TradingKey
TradingKey Direct company coverage

Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Neuronetics Inc's (STIM) dividend and stock split history. It notes that no dividends have been distributed in the past five years and there is no data available for stock splits. The page also includes current stock performance metrics and ma

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 00:40
Source
TradingKey
Stock Titan Direct company coverage

Madryn funds (NASDAQ: STIM) reallocate 72,500 Neuronetics RSU shares

Madryn Asset Management's affiliated funds have reallocated 72,500 Neuronetics (NASDAQ: STIM) RSU shares. These internal transfers, reported in an SEC Form 4 filing, involved shares granted as director compensation to Avinash Amin and moved among Madryn Health Partners II, Madryn

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Neuronetics (NASDAQ: STIM) director reallocates 42,500 shares to Madryn funds

Neuronetics (NASDAQ: STIM) director Avinash Amin reallocated 42,500 shares of common stock across three affiliated Madryn funds (Madryn Health Partners II, LP, Madryn Health Partners II (Cayman Master), LP, and Madryn Select Opportunities, LP) on June 15, 2026. These J-code trans

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 20:39
Source
Stock Titan